179 related articles for article (PubMed ID: 34165400)
1. Urine Cells-derived iPSCs: An Upcoming Frontier in Regenerative Medicine.
Gautam S; Biswas S; Singh B; Guo Y; Deng P; Deng W
Curr Med Chem; 2021; 28(31):6484-6505. PubMed ID: 34165400
[TBL] [Abstract][Full Text] [Related]
2. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing.
Yin X; Li Q; Shu Y; Wang H; Thomas B; Maxwell JT; Zhang Y
J Biomed Sci; 2024 May; 31(1):47. PubMed ID: 38724973
[TBL] [Abstract][Full Text] [Related]
3. Generation of mesenchymal stromal cells from urine-derived iPSCs of pediatric brain tumor patients.
Baliña-Sánchez C; Aguilera Y; Adán N; Sierra-Párraga JM; Olmedo-Moreno L; Panadero-Morón C; Cabello-Laureano R; Márquez-Vega C; Martín-Montalvo A; Capilla-González V
Front Immunol; 2023; 14():1022676. PubMed ID: 36776860
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming of Keratinocytes as Donor or Target Cells Holds Great Promise for Cell Therapy and Regenerative Medicine.
Zhang Y; Hu W; Ma K; Zhang C; Fu X
Stem Cell Rev Rep; 2019 Oct; 15(5):680-689. PubMed ID: 31197578
[TBL] [Abstract][Full Text] [Related]
5. Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Show Comparable Functionality to Their Autologous Origin.
Jakob M; Hambrecht M; Spiegel JL; Kitz J; Canis M; Dressel R; Streckfuss-Bömeke K
Cells; 2020 Dec; 10(1):. PubMed ID: 33379312
[TBL] [Abstract][Full Text] [Related]
6. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal and Induced Pluripotent Stem Cells-Derived Extracellular Vesicles: The New Frontier for Regenerative Medicine?
Barreca MM; Cancemi P; Geraci F
Cells; 2020 May; 9(5):. PubMed ID: 32397132
[TBL] [Abstract][Full Text] [Related]
8. Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease?
Cebrian-Serrano A; Stout T; Dinnyes A
Vet J; 2013 Oct; 198(1):34-42. PubMed ID: 24129109
[TBL] [Abstract][Full Text] [Related]
9. Human Adipose-Derived Pericytes: Biological Characterization and Reprogramming into Induced Pluripotent Stem Cells.
Ahmed TA; Shousha WG; Abdo SM; Mohamed IK; El-Badri N
Cell Physiol Biochem; 2020 Apr; 54(2):271-286. PubMed ID: 32233339
[TBL] [Abstract][Full Text] [Related]
10. Production of Mesenchymal Stem Cells Through Stem Cell Reprogramming.
Abdal Dayem A; Lee SB; Kim K; Lim KM; Jeon TI; Seok J; Cho AS
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003536
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem Cells Obtained from Synovial Fluid Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells on a Matrigel Coating Exhibited Enhanced Proliferation and Differentiation Potential.
Zheng YL; Sun YP; Zhang H; Liu WJ; Jiang R; Li WY; Zheng YH; Zhang ZG
PLoS One; 2015; 10(12):e0144226. PubMed ID: 26649753
[TBL] [Abstract][Full Text] [Related]
12. Towards Personalized Regenerative Cell Therapy: Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells.
Lin L; Bolund L; Luo Y
Curr Stem Cell Res Ther; 2016; 11(2):122-30. PubMed ID: 26201862
[TBL] [Abstract][Full Text] [Related]
13. Generation of Mesenchymal Stem Cells by Blood Cell Reprogramming.
Chen W; Baylink DJ; Lau KH; Zhang XB
Curr Stem Cell Res Ther; 2016; 11(2):114-21. PubMed ID: 26027679
[TBL] [Abstract][Full Text] [Related]
14. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review.
Bacakova L; Zarubova J; Travnickova M; Musilkova J; Pajorova J; Slepicka P; Kasalkova NS; Svorcik V; Kolska Z; Motarjemi H; Molitor M
Biotechnol Adv; 2018; 36(4):1111-1126. PubMed ID: 29563048
[TBL] [Abstract][Full Text] [Related]
15. Reprogrammed mesenchymal stem cells derived from iPSCs promote bone repair in steroid-associated osteonecrosis of the femoral head.
Zhou M; Xi J; Cheng Y; Sun D; Shu P; Chi S; Tian S; Ye S
Stem Cell Res Ther; 2021 Mar; 12(1):175. PubMed ID: 33712030
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of Urine-Derived Human Induced Pluripotent Stem Cells to Alveolar Type II Epithelial Cells.
Wang C; Hei F; Ju Z; Yu J; Yang S; Chen M
Cell Reprogram; 2016 Feb; 18(1):30-6. PubMed ID: 26679635
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial genome mutations in mesenchymal stem cells derived from human dental induced pluripotent stem cells.
Park J; Lee Y; Shin J; Lee HJ; Son YB; Park BW; Kim D; Rho GJ; Kang E
BMB Rep; 2019 Dec; 52(12):689-694. PubMed ID: 31234953
[TBL] [Abstract][Full Text] [Related]
19. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
Ye H; Wang Q
Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
[TBL] [Abstract][Full Text] [Related]
20. Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature.
Spitzhorn LS; Megges M; Wruck W; Rahman MS; Otte J; Degistirici Ö; Meisel R; Sorg RV; Oreffo ROC; Adjaye J
Stem Cell Res Ther; 2019 Mar; 10(1):100. PubMed ID: 30885246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
